MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Motor skills of walking in Parkinson’s disease: towards a better understanding of the cognitive abilities implicated in F8WT.

    V. Cian, M. Zarucchi, C. Siri, A. Giobbia, P. Ortelli, G. Frazzitta, M. Canesi (Gravedona Ed Uniti, Italy)

    Objective: to evaluate disease related and cognitive features involved in motor skills of walking in people with Parkinson’s disease (PWP). Background: curved path walking and…
  • MDS Virtual Congress 2021

    Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

    D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

    Objective: To consolidate the current literature pertaining to cognitive subtypes derived using data-driven methods in Parkinson’s Disease (PD). Background: Recent application of the Mild Cognitive…
  • MDS Virtual Congress 2021

    Interrogating Parkinson’s disease associated mutations at single cell resolution

    EGY. Chew, YJ. Heng, M. Lian, M. Tandiono, E. Dempster, S. Policicchio, J. Mill, R. Reynolds, JN. Foo (Singapore, Singapore)

    Objective: To uncover potentially causative Parkinson’s disease (PD) somatic mutations in post-mortem substantia nigra pars compacta (SNpc) tissues from sporadic PD patients using single cell…
  • MDS Virtual Congress 2021

    GBA variants in a multi-ethnic Parkinson’s disease (PD) cohort in Malaysia

    JL. Lim, K. Lohmann, AH. Tan, YW. Tay, KA. Ibrahim, Z. Abdul Aziz, AS. Mawardi, S. Datuk Puvanarajah, I. Looi, YK. Chia, TT. Lim, P. Bauer, A. Rolfs, C. Klein, A. Ahmad-Annuar, S-Y. Lim (Kuala Lumpur, Malaysia)

    Objective: To investigate the frequency of Glucocerebrosidase (GBA) gene variants in a multi-ethnic Parkinson’s disease (PD) cohort in Malaysia. Background: GBA variants have been associated…
  • MDS Virtual Congress 2021

    Reduced serum PRDX3 levels are a biomarker for Asian LRRK2 carriers in Parkinson’s disease

    YJ. Tan, ZH. Lu, EYL. Ng, SYE. Ng, NSY. Chia, ACW. Yong, XY. Choi, DD. Heng, S. Neo, ZY. Xu, KY. Tay, WL. Au, LCS. Tan, EK. Tan, ASL. Ng (Singapore, Singapore)

    Objective: We measured serum peroxiredoxin-3 (PRDX3) levels in Parkinson’s disease (PD) patients with and without LRRK2 risk variants, hypothesizing that PD LRRK2 carriers will show…
  • MDS Virtual Congress 2021

    Fatty acids and Glucocerebrosidase activity as potential biomarkers of stearyl-CoA desaturase inhibition; an observational study of inter and intraday variation in healthy volunteers and patients with Parkinson’s disease

    P. Eijsvogel, A. Gorbenko, D. Tardiff, M. Skupien, M. de Kam, P. Kremer, E. van Brummelen, B. Robertson, GJ. Groeneveld (Leiden, Netherlands)

    Objective: This study aimed to assess the naturally occurring levels and variation in plasma fatty acids (FA) and ceramide metabolism in healthy volunteers (HV) and…
  • MDS Virtual Congress 2021

    Biomarker candidates – Peptides identified to be differentially abundant in cerebrospinal fluid of patients with Parkinson´s disease

    L. Schilde, B. Serschnitzki, F. Maass, M. Bähr, P. Lingor, C. May, K. Marcus (Bochum, Germany)

    Objective: The aim of this study was to identify cerebrospinal fluid peptides that are differential in the cerebrospinal fluid of patients with Parkinson´s disease. Those…
  • MDS Virtual Congress 2021

    Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

    A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: We aimed to study the association between presynaptic striatal dopamine uptake and functional connectivity (FC) patterns among healthy first-degree relatives of PD patients with…
  • MDS Virtual Congress 2021

    Parkinson Disease with, but not without, Cognitive Decline Reveals Advanced Brain Aging

    MC. Kuo, CL. Chen, RM. Wu, WY. Tseng (Taipei, Taiwan)

    Objective: To investigate “brain age” in Parkinson disease (PD) with and without cognitive decline, and its correlation with motor and cognitive performance. Background: Although brain…
  • MDS Virtual Congress 2021

    Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease

    M. Schiess, J. Suescun, S. Chandra, V. Thyne, T. Ellmore (Houston, USA)

    Objective: Quantify cortical perfusion at baseline and six months after a single infusion of allogeneic bone marrow-derived mesenchymal stem cells (allo-hMSC) in relation to demographic…
  • « Previous Page
  • 1
  • …
  • 390
  • 391
  • 392
  • 393
  • 394
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley